Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia

被引：43
|
作者：
Shefer, Abigail [1 ]
Markowitz, Lauri [2 ]
Deeks, Shelley [3 ]
Tam, Theresa [4 ]
Irwin, Kathleen [5 ]
Garland, Suzanne M. [6 ]
Schuchat, Anne [1 ]
机构：
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA
[3] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Immunisat & Resp Div, Ottawa, ON, Canada
[4] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Immunizat & Resp Infect Div, Ottawa, ON, Canada
[5] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland
[6] Univ Melbourne, Dept Obstet & Gynaecol, Royal Hosp Women, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia
来源：
VACCINE | 2008年 / 26卷
关键词：
Human Papillomavirus; Vaccine; Vaccine schedule; Financing; Implementation;
D O I：
10.1016/j.vaccine.2008.05.065
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Successful incorporation of a new vaccine into a nation's vaccination program requires addressing a number of issues, including: 1) establishing national recommendations; 2) assuring education of and acceptance by the public and medical community; 3) establishing and maintaining an appropriate infrastructure for vaccine delivery; 4) financing the vaccine and the program, in addition to political will. This article reviews the early experience with implementation of human papillomavirus (HPV) vaccination programs. It focuses on the United States of America and Canada and provides a brief report on Australia, where introduction is underway. Published by Elsevier Ltd.
引用
收藏
页码：K68 / K75
页数：8
相关论文
共 50 条
  • [1] Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States
    Steinau, Martin
    Saraiya, Mona
    Goodman, Marc T.
    Peters, Edward S.
    Watson, Meg
    Cleveland, Jennifer L.
    Lynch, Charles F.
    Wilkinson, Edward J.
    Hernandez, Brenda Y.
    Copeland, Glen
    Saber, Maria S.
    Hopenhayn, Claudia
    Huang, Youjie
    Cozen, Wendy
    Lyu, Christopher
    Unger, Elizabeth R.
    EMERGING INFECTIOUS DISEASES, 2014, 20 (05) : 822 - 828
  • [2] Human Papillomavirus Vaccine Hesitancy in the United States
    Morales-Campos, Daisy Y.
    Zimet, Gregory D.
    Kahn, Jessica A.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2023, 70 (02) : 211 - 226
  • [3] Another Look at the Human Papillomavirus Vaccine Experience in Canada
    Mah, Catherine L.
    Deber, Raisa B.
    Guttmann, Astrid
    McGeer, Allison
    Krahn, Murray
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2011, 101 (10) : 1850 - 1857
  • [4] Human Papillomavirus Prevalence in Invasive Anal Cancers in the United States Before Vaccine Introduction
    Steinau, Martin
    Unger, Elizabeth R.
    Hernandez, Brenda Y.
    Goodman, Marc T.
    Copeland, Glenn
    Hopenhayn, Claudia
    Cozen, Wendy
    Saber, Maria S.
    Huang, Youjie
    Peters, Edward S.
    Lynch, Charles F.
    Wilkinson, Edward J.
    Rajeevan, Mangalathu S.
    Lyu, Christopher
    Saraiya, Mona
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2013, 17 (04) : 397 - 403
  • [5] Early Policy Responses to the Human Papillomavirus Vaccine in the United States, 2006-2010
    Laugesen, Miriam J.
    Mistry, Ritesh
    Carameli, Kelley A.
    Ribisl, Kurt M.
    Needleman, Jack
    Bastani, Roshan
    JOURNAL OF ADOLESCENT HEALTH, 2014, 55 (05) : 659 - 664
  • [6] Early Adoption of the Human Papillomavirus Vaccine Among Hispanic Adolescent Males in the United States
    Reiter, Paul L.
    Brewer, Noel T.
    Gilkey, Melissa B.
    Katz, Mira L.
    Paskett, Electra D.
    Smith, Jennifer S.
    CANCER, 2014, 120 (20) : 3200 - 3207
  • [7] The Human Papillomavirus Vaccine in Canada
    Shaun K. Morris
    Claire K. Nguyen
    Canadian Journal of Public Health, 2008, 99 : 114 - 116
  • [8] The human papillomavirus vaccine in Canada
    Morris, Shaun K.
    Nguyen, Claire K.
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2008, 99 (02): : 114 - 116
  • [9] Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018
    Rosenblum, Hannah G.
    Lewis, Rayleen M.
    Gargano, Julia W.
    Querec, Troy D.
    Unger, Elizabeth R.
    Markowitz, Lauri E.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 918 - +
  • [10] Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
    Gold, Michael S.
    Buttery, Jim
    McIntyre, Peter
    SEXUAL HEALTH, 2010, 7 (03) : 320 - 324
12345